BS Andersson

788 total citations
10 papers, 615 citations indexed

About

BS Andersson is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, BS Andersson has authored 10 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in BS Andersson's work include Hematopoietic Stem Cell Transplantation (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Acute Myeloid Leukemia Research (2 papers). BS Andersson is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Acute Myeloid Leukemia Research (2 papers). BS Andersson collaborates with scholars based in United States and Argentina. BS Andersson's co-authors include Koen van Besien, Rakesh Mehra, Donna Przepiorka, Marcos de Lima, Karen R. Cleary, David F. Claxton, J. P. Hester, L Nagarajan, Claire Dyer and YO Huh and has published in prestigious journals such as Blood, British Journal of Cancer and Leukemia.

In The Last Decade

BS Andersson

10 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
BS Andersson United States	9	379	240	162	149	124	10	615
CA Koller United States	7	168 0.4×	136 0.6×	104 0.6×	109 0.7×	179 1.4×	15	510
Eugenia Giraldi Italy	11	518 1.4×	247 1.0×	171 1.1×	48 0.3×	288 2.3×	22	885
IM Chen United States	5	309 0.8×	187 0.8×	117 0.7×	76 0.5×	164 1.3×	8	506
Deborah B. Aquino United States	9	256 0.7×	165 0.7×	211 1.3×	217 1.5×	72 0.6×	10	651
Annunziata Manna Italy	10	139 0.4×	174 0.7×	138 0.9×	228 1.5×	59 0.5×	29	485
Junichi Ueyama Japan	11	204 0.5×	171 0.7×	75 0.5×	52 0.3×	162 1.3×	35	545
Fábio R. Kerbauy Brazil	11	291 0.8×	153 0.6×	87 0.5×	58 0.4×	48 0.4×	45	474
ED Thomas United States	14	634 1.7×	177 0.7×	229 1.4×	55 0.4×	108 0.9×	28	841
Kaoru Nagata Japan	13	295 0.8×	80 0.3×	75 0.5×	65 0.4×	181 1.5×	54	490
Anthony S. Kurec United States	11	159 0.4×	68 0.3×	155 1.0×	155 1.0×	99 0.8×	32	484

Countries citing papers authored by BS Andersson

Since Specialization

Citations

This map shows the geographic impact of BS Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BS Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BS Andersson more than expected).

Fields of papers citing papers by BS Andersson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BS Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BS Andersson. The network helps show where BS Andersson may publish in the future.

Co-authorship network of co-authors of BS Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of BS Andersson. A scholar is included among the top collaborators of BS Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BS Andersson. BS Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Przepiorka, Donna, I. Khouri, Cindy Ippoliti, et al.. (1999). Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone Marrow Transplantation. 24(7). 763–768. 58 indexed citations

2.

Besien, Koen van, Marcos de Lima, Gabriela Rondón, et al.. (1997). Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplantation. 19(10). 977–982. 175 indexed citations

3.

Dignani, María Cecilia, E. Anaissie, J. P. Hester, et al.. (1997). Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 11(10). 1621–1630. 107 indexed citations

4.

Lima, Marcos de, Koen van Besien, Rakesh Mehra, et al.. (1997). Bone marrow transplantation after failure of autologous transplant for non-Hodgkin’s lymphoma. Bone Marrow Transplantation. 19(2). 121–127. 56 indexed citations

5.

Claxton, David F., CL Reading, L Nagarajan, et al.. (1992). Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia [see comments]. Blood. 80(3). 582–586. 77 indexed citations

6.

Claxton, David F., CL Reading, L Nagarajan, et al.. (1992). Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia [see comments]. Blood. 80(3). 582–586. 54 indexed citations

7.

Hester, J. P., et al.. (1992). Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte- macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin. Blood. 79(12). 3388–3393. 35 indexed citations

8.

Murray, David, et al.. (1990). Resistance to 4′-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia. British Journal of Cancer. 61(1). 51–55. 3 indexed citations

9.

Andersson, BS, et al.. (1987). Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines. Blood. 69(3). 721–726. 22 indexed citations

10.

Andersson, BS, et al.. (1987). Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines. Blood. 69(3). 721–726. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact